GLIMEDOM MV 2/0.2
Effectively controls Diabetes & Obesity
| Packing | 10x10 ALU-PVC Blister |
| Dosage Form | Tablet |
| Category | Pharma |
| GST | 5% |
GLIMEDOM MV 2/0.2
Glimedom MV 2/0.2 is a first choice combination of Glimepiride 2 mg + Metformin (Prolonged release) 500 mg + Voglibose 0.2 mg to manage Hyperglycemia. This medicine achieves good glycemic control with better tolerability profile and improves the lipid profile. The combination can be used in Type-2 Diabetes and in Diabetes with or without Obesity.
USPs
- Certified Facility
- Excellent Packing.
- Bilayer tablet for better drug control and stability.
- Lower risk of hypoglycaemia & less weight gain than other sulfonylureas.
- Combination achieves good glycemic control with better tolerability profile.
- Reduces Blood Glucose more rapidly than Glipizide over first few weeks of treatment
- Safe in Patients with Cardiovascular Disease.
- Increased patient compliance due to small tablet size.
